Intra-Cellular Therapies, Inc. Reports Fourth Quarter And Full-Year 2013 Financial Results

Published: Mar 26, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK, March 25, 2014 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced its financial results for the fourth quarter and year ended December 31, 2013, and provided an update on corporate developments and upcoming events.

Help employers find you! Check out all the jobs and post your resume.

Back to news